English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [916]
News [2620]
Articles [112]
Editorials [3]
Conferences [85]
elearning [27]
European action against rare cancers
Dr Paolo Casali - Executive Commitee Member, European Society for Medical...
European action against rare cancers ( Dr Paolo Casali  - Executive Commitee Member, European Society for Medical Oncology )
4 Nov 2009
ECCO 15 - ESMO 34 Conference
Prof José Baselga - President of ESMO
ECCO 15 - ESMO 34 Conference ( Prof José Baselga - President of ESMO )
4 Nov 2009
Targeted agents in the treatment of advanced NSCLC
Prof Johan Vansteenkiste - Leuven University Hospital, Belgium
Targeted agents in the treatment of advanced NSCLC ( Prof Johan Vansteenkiste -  Leuven University Hospital, Belgium )
2 Nov 2009
ECCO 15 - ESMO 34 News 23rd September 2009
Prof Gordon McVie - ecancer Managing Editor
ECCO 15 - ESMO 34 News 23rd September 2009 ( Prof Gordon McVie - ecancer Managing Editor )
23 Sep 2009
ECCO 15 - ESMO 34 News 22nd September 2009
Prof Gordon McVie - ecancer Managing Editor
ECCO 15 - ESMO 34 News 22nd September 2009 ( Prof Gordon McVie - ecancer Managing Editor )
22 Sep 2009
ECCO 15 - ESMO 34 News 20-21 September, 2009
Prof Gordon McVie - ecancer Managing Editor
ECCO 15 - ESMO 34 News 20-21 September, 2009 ( Prof Gordon McVie - ecancer Managing Editor )
21 Sep 2009
ECCO 15 - ESMO 34 Chairs: Why join us in Berlin?
Why attend ECCO 15 - ESMO 34?
ECCO 15 - ESMO 34 Chairs: Why join us in Berlin? ( Why attend ECCO 15 - ESMO 34? )
22 Jul 2009
The Oncopolicy Roundtable: ECCO's President and special guests highlight key...
ECCO 15 - ESMO 34
The Oncopolicy Roundtable: ECCO's President and special guests highlight key issues ( ECCO 15 - ESMO 34 )
22 Jul 2009
Selecting appropriate first line lung cancer therapy
Dr Paul Bunn - University of Colorado, Denver, USA
Selecting appropriate first line lung cancer therapy ( Dr Paul Bunn - University of Colorado, Denver, USA )
8 Jul 2009
Lung cancer patients lacking MSH2 DNA repair protein fare better with chemo
Dr Pierre Fouret - Institut Gustave Roussy, France
Lung cancer patients lacking MSH2 DNA repair protein fare better with chemo ( Dr Pierre Fouret - Institut Gustave Roussy, France )
3 Jul 2009
Targeting death receptors in chemo-resistant cancer cells
Prof Patrick Johnston - Queen's University Belfast, UK
Targeting death receptors in chemo-resistant cancer cells ( Prof Patrick Johnston - Queen's University Belfast, UK )
3 Jul 2009
ASCO: Pemetrexed extends survival as maintenance therapy
Dr. Chandra P. Belani - Penn State Cancer Institute, Hershey, Pennsylvania, USA
ASCO: Pemetrexed extends survival as maintenance therapy ( Dr. Chandra P. Belani - Penn State Cancer Institute, Hershey, Pennsylvania, USA )
18 Jun 2009
<1...7374757677>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top